SG34210A1 - Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract - Google Patents

Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract

Info

Publication number
SG34210A1
SG34210A1 SG1995000074A SG1995000074A SG34210A1 SG 34210 A1 SG34210 A1 SG 34210A1 SG 1995000074 A SG1995000074 A SG 1995000074A SG 1995000074 A SG1995000074 A SG 1995000074A SG 34210 A1 SG34210 A1 SG 34210A1
Authority
SG
Singapore
Prior art keywords
active ingredient
medicinal active
targeted site
pharmaceutical preparation
intestinal tract
Prior art date
Application number
SG1995000074A
Other languages
English (en)
Inventor
Yoshiyuki Hirakawa
Hiroyuki Yoshino
Eiji Fukui
Tami Hanamori
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12593695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG34210(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG34210A1 publication Critical patent/SG34210A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1995000074A 1994-03-11 1995-03-08 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract SG34210A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6040911A JP2917799B2 (ja) 1994-03-11 1994-03-11 消化管内適所放出型製剤

Publications (1)

Publication Number Publication Date
SG34210A1 true SG34210A1 (en) 1996-12-06

Family

ID=12593695

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995000074A SG34210A1 (en) 1994-03-11 1995-03-08 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract

Country Status (14)

Country Link
US (1) US5725880A (de)
EP (1) EP0671168B1 (de)
JP (1) JP2917799B2 (de)
KR (1) KR100305234B1 (de)
CN (1) CN1116523A (de)
AT (1) ATE193439T1 (de)
CA (1) CA2144094C (de)
DE (1) DE69517218T2 (de)
DK (1) DK0671168T3 (de)
ES (1) ES2148365T3 (de)
GR (1) GR3033593T3 (de)
PT (1) PT671168E (de)
SG (1) SG34210A1 (de)
TW (1) TW422708B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2120354B1 (es) * 1996-02-12 1999-07-01 Univ Sevilla Dispositivo terapeutico para direccionar farmacos hacia el tramo del tracto gastrointestinal deseado en funcion de las caracteristicas fisicoquimicas del mismo.
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CN1163223C (zh) 1998-07-28 2004-08-25 田边制药株式会社 肠内目标部位释放型制剂
ES2197600T3 (es) 1999-01-29 2004-01-01 Disphar International B.V. Composiciones farmaceuticas.
FR2790387B1 (fr) * 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
EP1252887A4 (de) * 2000-01-27 2009-07-29 Mitsubishi Tanabe Pharma Corp Zubereitung mit verlängerter freisetzung und prozess zu deren herstellung
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
EP1607087A1 (de) * 2003-03-27 2005-12-21 Hisamitsu Pharmaceutical Co., Inc. Medizinische, oral einzunehmende präparate zur abgabe im dickdarm, medizinische, oral einzunehmende präparate zur behandlung von dickdarmkrebs und medizinische, oral einzunehmende präparate zur behandlung von dickdarmentzündung
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
WO2007010846A1 (ja) * 2005-07-15 2007-01-25 Kissei Pharmaceutical Co., Ltd. 胃内滞留製剤
JP5140586B2 (ja) * 2005-07-29 2013-02-06 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 滅菌パンクレアチン粉末の製法
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
CN101242811B (zh) 2005-08-15 2015-06-17 雅培实验室有限公司 酸不稳定性药物的控释药物组合物
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
CA2673485A1 (en) * 2007-01-15 2008-07-24 Kissei Pharmaceutical Co., Ltd. Gastric retention-type sustained-release levodopa preparation
WO2008132727A2 (en) * 2007-04-26 2008-11-06 Technion Research And Development Foundation Ltd Oral delivery of proteins and peptides
JP2010529197A (ja) * 2007-06-13 2010-08-26 ジェイ プラーヴダ， 酸化的ストレス関連疾患の治療および診断のための材料および方法
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EA022886B1 (ru) 2008-10-03 2016-03-31 Др. Фальк Фарма Гмбх Способ поддержания ремиссии язвенного колита у пациентов
EP2255794A1 (de) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Magensaftresistenter Überzug
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
EP3439676B1 (de) 2016-04-04 2021-06-09 Omeza LLC Topische fischölzusammensetzung
EP3749289A4 (de) * 2018-02-06 2021-11-17 Robert Niichel Multipartikulärer stoff mit pharmazeutischen oder probiotischen wirkstoffen
AU2022307756A1 (en) * 2021-07-09 2024-02-22 Evonik Operations Gmbh Composition comprising a (meth)acrylate copolymer, an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid and specific glidants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3608030A (en) * 1969-05-21 1971-09-21 Howard Tint Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
CA1308357C (en) * 1987-01-28 1992-10-06 Tohru Chiba Method for the preparation of a coated solid medicament
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition

Also Published As

Publication number Publication date
JP2917799B2 (ja) 1999-07-12
EP0671168B1 (de) 2000-05-31
ATE193439T1 (de) 2000-06-15
CA2144094A1 (en) 1995-09-12
PT671168E (pt) 2000-09-29
DK0671168T3 (da) 2000-08-07
US5725880A (en) 1998-03-10
KR950031046A (ko) 1995-12-18
KR100305234B1 (ko) 2002-04-24
TW422708B (en) 2001-02-21
JPH07247222A (ja) 1995-09-26
DE69517218T2 (de) 2000-11-30
EP0671168A1 (de) 1995-09-13
ES2148365T3 (es) 2000-10-16
DE69517218D1 (de) 2000-07-06
GR3033593T3 (en) 2000-09-29
CA2144094C (en) 2004-01-27
CN1116523A (zh) 1996-02-14

Similar Documents

Publication Publication Date Title
GR3033593T3 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract.
MX9500885A (es) Preparacion farmaceutica para administracion oral.
ATE205705T1 (de) Arzneimittel zum wirkstoff - targetting in den dickdarm
WO1998056360A3 (en) Film-coated tablet for improved upper gastrointestinal tract safety
HU9302379D0 (en) Peroral medical preparatives with retarded releasing of active agents for treating intestinal diseases
HK1035492A1 (en) Devices for providing prolonged drug therapy.
DE69727153D1 (de) Im magen verweilende orale arzneistoffdosisformen zur gesteuerten freisetzung schwerlöslicher arzneistoffe und unlöslicher stoffe
WO2007079082A3 (en) Gastric release pulse system for drug delivery
NO20003640L (no) Ny doseringsform
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
NO940376L (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
DK0621032T3 (da) Lægemiddelform med reguleret afgivelse
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
WO1998026767A3 (en) Site-specific controlled release dosage formulation for mesalamine
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP0271151A3 (de) Azumolen-Dosisformen
JP2001514218A5 (de)
RU2001131112A (ru) Препаративная форма для введения в подвздошную кишку, включающая соединение, ингибирующее транспорт подвздошнокишечной желчной кислоты
IL122719A (en) Controlled release pharmaceutical dosage forms for oral administration containing nifedipine as active substance and process for their preparation